Commitment towards creating consistent value for our shareholders
Press Release - Eugia Pharma receives USFDA approval for Dasatinib Tablets
Press Release - Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP
Completion of US FDA Inspection at Raleigh Plant, North Carolina, owned by Aurolife Pharma LLC
Press Release CuraTeQ Biologics completes a successful Phase 1 Pharmacokinetics study of Denosumab BP16
CuraTeQ Biologics s.r.o received Marketing Authorization for Dyrupeg
Update on Cautionary Email received from the stock exchanges regarding delay in intimation of Schedule of Investors Meet.
Update on solar power purchase agreement and acquisition upto 26 stake in Swarnaaskshu Solar Power Private Limited.
Allotment of Compulsory Convertible Preference Shares to Dr. Satakarni Makkapati Curateq Biologics Private Limited
Classification of US FDA Inspection at Unit V of Apitoria Pharma Private Limited
Termination of License Agreement with Hilleman Laboratories Singapore Pte, Limited by Auro Vaccines Private Limited
Order received from the Oo Deputy Commissioner ST FAC, STU1, Punjagutta Hyderabad
Completion of purchase of entire 80 of the equity share capital of Tergene Biotech Limited
Classification of US FDA Inspection at one of the warehouses of Aurobindo Pharma USA Inc.
Completion of US FDA Pre-Approval Inspection PAI at Eugia Steriles Private Limited
CuraTeQ Biologics received Marketing Authorisation for Zefylti, a filgrastim biosimilar
Clarification w.r.t. intimation dated January 28, 2025 - US FDA
Outcome of Board Meeting 06.02.2025
Purchase of entire 80 shares of Tergene held by Auro Vaccines and make it a direct subsidiary of the Company.
To acquire 26 stake in Swarnaaskshu Solar Power Private Limited
Orders from the Additional Commissioner of Central Tax, Ranga Reddy GST Commissionerate, Hyderabad
Press Release CuraTeQ Biologics s.r.o, receives positive opinion from CHMP EMA for Dyrupeg
Orders from the Deputy Commissioner ST STU-1 Punjagutta Division, Hyderabad
Unit 2 of Apitoria Pharma Pvt. Ltd., received EIR from US FDA with VAI classification
